ImmunGene

ImmunGene is a drug discovery and development company. The company is developing advanced monoclonal antibody-based therapeutics for the treatment of cancer, autoimmune disorders and other diseases.

ImmunGene is leveraging promising science to tap the power of the immune systems to develop therapeutic antibodies that are optimized for efficacy and a superior safety profile.

Its technology enables the company to fuse cytotoxic cytokines to antibodies to selectively target disease causing cells and tissues and reduce the systemic toxicity of the cytokines.

ImmunGene is working on making novel drug candidates for treating diseases that affect millions of people globally. The primary focus of ImmunGene is on a safe and effective treatment for cancer. It also has programs underway for treating other potentially chronic diseases, including infections.